Equitable Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $463K | Sell |
881
-44
| -5% | -$23.1K | ﹤0.01% | 1029 |
|
|
2025
Q1 | $587K | Buy |
925
+36
| +4% | +$22.8K | 0.01% | 868 |
|
|
2024
Q4 | $633K | Sell |
889
-217
| -20% | -$155K | 0.01% | 811 |
|
|
2024
Q3 | $1.16M | Buy |
1,106
+31
| +3% | +$32.6K | 0.01% | 638 |
|
|
2024
Q2 | $1.13M | Buy |
1,075
+55
| +5% | +$57.8K | 0.01% | 624 |
|
|
2024
Q1 | $982K | Buy |
1,020
+29
| +3% | +$27.9K | 0.01% | 627 |
|
|
2023
Q4 | $870K | Buy |
991
+30
| +3% | +$26.3K | 0.01% | 619 |
|
|
2023
Q3 | $791K | Sell |
961
-27
| -3% | -$22.2K | 0.01% | 602 |
|
|
2023
Q2 | $710K | Buy |
988
+21
| +2% | +$15.1K | 0.01% | 606 |
|
|
2023
Q1 | $795K | Buy |
967
+14
| +1% | +$11.5K | 0.01% | 533 |
|
|
2022
Q4 | $688K | Buy |
953
+312
| +49% | +$225K | 0.01% | 534 |
|
|
2022
Q3 | $442K | Sell |
641
-37
| -5% | -$25.5K | 0.01% | 588 |
|
|
2022
Q2 | $401K | Sell |
678
-45
| -6% | -$26.6K | 0.01% | 613 |
|
|
2022
Q1 | $505K | Buy |
+723
| New | +$505K | 0.01% | 569 |
|
|
2021
Q4 | – | Sell |
-458
| Closed | -$277K | – | 884 |
|
|
2021
Q3 | $277K | Buy |
+458
| New | +$277K | ﹤0.01% | 698 |
|